Profile | GDS4284 / 239210_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 95.6605 | 36 |
GSM687648 | Patient 402 control | 170.209 | 46 |
GSM687653 | Patient 403 control | 36.2599 | 19 |
GSM687658 | Patient 404 control | 190.065 | 47 |
GSM687663 | Patient 411 control | 60.5831 | 24 |
GSM687668 | Patient 422 control | 91.2 | 33 |
GSM687673 | Patient 424 control | 233.616 | 50 |
GSM687678 | Patient 425 control | 88.0505 | 31 |
GSM687683 | Patient 427 control | 246.69 | 50 |
GSM687688 | Patient 428 control | 35.0034 | 19 |
GSM687695 | Patient 441 control | 907.198 | 73 |
GSM687699 | Patient 443 control | 123.423 | 34 |
GSM687704 | Patient 444 control | 62.4297 | 26 |
GSM687707 | Patient 448 control | 159.99 | 40 |
GSM687712 | Patient 449 control | 111.465 | 36 |
GSM687719 | Patient 450 control | 341.056 | 55 |
GSM687724 | Patient 451 control | 427.335 | 61 |
GSM687728 | Patient 452 control | 162.695 | 43 |
GSM687646 | Patient 401 treated 24h | 60.7626 | 26 |
GSM687649 | Patient 402 treated 24h | 125.894 | 41 |
GSM687665 | Patient 411 treated 24h | 154.132 | 41 |
GSM687651 | Patient 402 treated 4 weeks | 196.233 | 47 |
GSM687667 | Patient 411 treated 4 weeks | 77.7604 | 29 |
GSM687670 | Patient 422 treated 24h | 110.759 | 35 |
GSM687671 | Patient 422 treated 4 weeks | 125.31 | 40 |
GSM687654 | Patient 403 treated 24h | 72.5021 | 31 |
GSM687675 | Patient 424 treated 24h | 178.556 | 44 |
GSM687685 | Patient 427 treated 24h | 243.618 | 52 |
GSM687656 | Patient 403 treated 4 weeks | 61.0019 | 28 |
GSM687677 | Patient 424 treated 4 weeks | 135.233 | 41 |
GSM687687 | Patient 427 treated 4 weeks | 63.4887 | 28 |
GSM687692 | Patient 428 treated 4h | 40.8667 | 20 |
GSM687716 | Patient 449 treated 4h | 67.8489 | 27 |
GSM687722 | Patient 450 treated 4h | 322.551 | 55 |
GSM687680 | Patient 425 treated 24h | 74.9083 | 29 |
GSM687690 | Patient 428 treated 24h | 53.5527 | 24 |
GSM687700 | Patient 443 treated 24h | 225.575 | 43 |
GSM687705 | Patient 444 treated 24h | 104.699 | 37 |
GSM687714 | Patient 449 treated 24h | 90.9588 | 34 |
GSM687721 | Patient 450 treated 24h | 513.264 | 63 |
GSM687682 | Patient 425 treated 4 weeks | 56.3431 | 25 |
GSM687694 | Patient 428 treated 4 weeks | 45.2323 | 23 |
GSM687702 | Patient 443 treated 4 weeks | 82.8462 | 29 |
GSM687718 | Patient 449 treated 4 weeks | 45.6875 | 21 |
GSM687723 | Patient 450 treated 4 weeks | 120.965 | 37 |
GSM687661 | Patient 404 treated 4h | 111.122 | 35 |
GSM687710 | Patient 448 treated 4h | 198.931 | 48 |
GSM687726 | Patient 451 treated 4h | 409.081 | 59 |
GSM687730 | Patient 452 treated 4h | 470.16 | 54 |
GSM687660 | Patient 404 treated 24h | 655.511 | 69 |
GSM687697 | Patient 441 treated 24h | 461.612 | 60 |
GSM687709 | Patient 448 treated 24h | 186.78 | 45 |
GSM687725 | Patient 451 treated 24h | 590.339 | 66 |
GSM687729 | Patient 452 treated 24h | 490.184 | 63 |
GSM687727 | Patient 451 treated 4 weeks | 155.638 | 40 |
GSM687731 | Patient 452 treated 4 weeks | 166.112 | 42 |